Skip to content

Uitgebreide analyse van de stofwisseling van patiënten die bariatrische chirurgie ondergaan.

Extended metabolic phenotyping of subjects undergoing bariatric surgery.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON21979
Enrollment
1200
Registered
2011-10-26
Start date
2011-10-27
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obesity, insulin resistance, metabolic syndrome, obesitas, insulineresistentie, metabool syndroom

Interventions

None listed

Sponsors

Academic Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Scheduled for malabsorptive bariatric surgery; 2. Age 18-65 years; 3. Stable weight for 3 months prior to inclusion.

Exclusion criteria

Exclusion criteria: 1. Major bleeding disorder; 2. Renal insufficiency (creatinine > 150 umol/L), liver enzymes > 3x ULN; 3. All medical conditions except for obesity related diseases and thyroid disorders; 4. Unable to read or speak the Dutch language.

Design outcomes

Primary

MeasureTime frame
1. To identify predictive variables correlated with percentage excess weight loss (EWL), reversal of metabolic complications of obesity, quality of life after bariatric surgery and postoperative complications (special focus on inflammatory pathways and eating behavior); 2. To identify metabolic variables (using a metabolomics approach) in plasma and tissue (adipose tissue as well as liver) correlated with metabolic health c.q. markers of the metabolic syndrome.

Secondary

MeasureTime frame
1. To assess the prevalence of hypertension and metabolic complications of obesity in obese patients scheduled for bariatric surgery; 2. To study the association of eating behavior with possible polymorphisms involved in appetite regulation and with markers of metabolic health.

Contacts

Public ContactMurat Kilicarslan
m.kilicarslan@amc.uva.nl+31 (0)20 5663507

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)